S. Agewall

发表

serum of rats after stressful, prolonged intense exercise Cardiac troponin T alterations in myocardium and

A. E. Costa, S. Lipshultz, F. Apple, 2015 .

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Jeroen J. Bax, D. Dudek, D. Zahger, 2012 .

Troponin elevation in coronary vs. non-coronary disease.

H. Katus, E. Giannitsis, S. Agewall, 2011, European heart journal.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

P. Kolh, M. Taskinen, G. De Backer, 2011, European heart journal.

2016 European Guidelines on cardiovascular disease prevention in clinical practice.

A. Hoes, N. Sattar, P. Marques‐Vidal, 2016, Revista espanola de cardiologia.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

P. Kirchhof, G. Lip, U. Schotten, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

P. Kirchhof, G. Lip, U. Schotten, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Urinary albumin excretion is associated with the intima‐media thickness of the carotid artery in hypertensive males with non‐insulin‐dependent diabetes mellitus

B. Fagerberg, S. Agewall, J. Wikstrand, 1995, Journal of hypertension.

Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope

G. Hindricks, C. Morillo, I. Simpson, 2018, European heart journal.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Marco Valgimigli, Marco Roffi, Pascal Vranckx, 2018, European heart journal.

EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

Ian Graham, Christian Albus, Christi Deaton, 2005 .

Matrix metalloproteinases and cardiovascular disease.

Stefan Agewall, S. Agewall, 2006, European heart journal.

Relationship Between Oxidized LDL, IgM, and IgG Autoantibodies to ox-LDL Levels With Recurrent Cardiovascular Events in Swedish Patients With Previous Myocardial Infarction

S. Agewall, M. Crisby, L. Henareh, 2014, Angiology.

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

B. Lewis, J. Tamargo, G. Rosano, 2018, European heart journal.

Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.

L. Wallentin, S. Agewall, T. Jernberg, 2010, The American journal of cardiology.

Obstructive sleep apnea: no independent association to troponins

Morten Wang Fagerland, D. Atar, S. Agewall, 2014, Sleep and Breathing.

Multiple risk intervention in high-risk hypertensive patients. A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Risk Intervention Study (RIS) Group.

B. Fagerberg, S. Agewall, J. Wikstrand, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Gender issues in cardiovascular medicine

S. Agewall, K. Kublickiene, 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of tissue harmonic imaging and contrast upon between observer and test–retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure

R. Doughty, G. Gamble, N. Sharpe, 2004, European journal of heart failure.

Increases of creatine kinase MB and cardiac troponin T in serum of a patient with uterine leiomyosarcoma.

S. Agewall, 2000, Clinical chemistry.

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.

D. Atar, K. Dickstein, F. Zannad, 2018, International journal of cardiology.

Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS).

D. Atar, S. Agewall, V. Serebruany, 2018, European heart journal. Cardiovascular pharmacotherapy.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation – Web Addenda

G. Hindricks, F. Crea, A. Kastrati, 2017 .

The large clinical statin trials.

S. Agewall, 2011, International journal of cardiology.

Endothelial function in conduit and resistance arteries in men with coronary disease.

S. Agewall, L. Henareh, K. Kublickiene, 2006, Atherosclerosis.

Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

D. Atar, J. Cleland, H. Katus, 2020, Heart Failure Reviews.

Atherosclerosis: Recent trials, new targets and future directions.

F. Zannad, W. Koenig, A. Leite-Moreira, 2015, International journal of cardiology.

Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease.

K. Schenck-Gustafsson, S. Agewall, K. Kublickiene, 2008, Atherosclerosis.

Should oral glucose tolerance test be a routine examination after a myocardial infarction?

S. Agewall, L. Henareh, M. Berglund, 2004, International journal of cardiology.

Oral antiplatelet agents in ACS: from pharmacology to clinical differences

L. Badimón, S. Agewall, T. Simon, 2011, Fundamental & clinical pharmacology.

Myocardial infarction with angiographically normal coronary arteries.

S. Agewall, T. Jernberg, P. Tornvall, 2011, Atherosclerosis.

Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working

D. Atar, B. Lewis, L. Lund, 2019, European heart journal. Cardiovascular pharmacotherapy.

Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.

S. Agewall, C. Sylvén, S. Saha, 2008, International Journal of Cardiology.

Non‐invasive assessment of endothelial function – relation between vasodilatory responses in skin microcirculation and brachial artery

S. Agewall, L. Henareh, Jimmy Hansell, 2004, Clinical physiology and functional imaging.

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology

G. Lip, D. Atar, B. Lewis, 2015, European heart journal.

Microalbuminuria, insulin sensitivity and haemostatic factors in non‐diabetic treated hypertensive men

B. Fagerberg, S. Agewall, J. Wikstrand, 1995, Journal of internal medicine.

Carbohydrate-deficient transferrin is associated with insulin sensitivity in hypertensive men.

B. Fagerberg, S. Agewall, P. Lundberg, 1994, The Journal of clinical endocrinology and metabolism.

Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk.

B. Fagerberg, S. Agewall, J. Wikstrand, 1995, Stroke.

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.

G. Lip, K. Huber, S. Agewall, 2015, International journal of cardiology.

Focus on pharma in acute coronary syndrome.

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association

H. Jneid, A. Bolger, T. Brown, 2019, Circulation.

Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study

S. Agewall, T. Jernberg, P. Tornvall, 2013, Journal of internal medicine.

Intima‐Media Thickness of Common Carotid and Brachial Arteries and Prothrombin Fragment 1 + 2 Are Associated with Left Ventricular Diastolic Dysfunction in Patients with Myocardial Infarction

L. Brodin, S. Agewall, T. Jogestrand, 2010, Echocardiography.

Esomeprazole for Prevention and Resolution of Upper Gastrointestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection: The OBERON Trial

Á. Lanas, S. Agewall, J. Herlitz, 2013, Journal of cardiovascular pharmacology.

Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.

B. Lewis, S. Pocock, J. Tamargo, 2021, European heart journal. Cardiovascular pharmacotherapy.

Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease.

S. Agewall, K. Kublickiene, L. Luksha, 2009, Atherosclerosis.

Matrix metalloproteinases in atherothrombosis.

S. Agewall, M. Bäck, D. Ketelhuth, 2010, Progress in cardiovascular diseases.

Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.

D. Atar, K. Dickstein, F. Zannad, 2017, International journal of cardiology.

Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

G. Hindricks, P. Kolh, P. Ponikowski, 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Atorvastatin normalizes endothelial function in healthy smokers.

S. Agewall, A. Hernberg, 2006, Clinical science.

Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries.

K. Cederlund, S. Agewall, T. Jernberg, 2015, The American journal of cardiology.

Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study

D. Atar, H. Katus, S. Agewall, 2015, Circulation. Heart failure.

Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study.

B. Fagerberg, S. Agewall, J. Wikstrand, 1998, American journal of hypertension.

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

D. Atar, R. de Caterina, G. Rosano, 2016, European heart journal.

Critical appraisal of the COMPASS trial.

S. Agewall, A. Niessner, 2018, European heart journal. Cardiovascular pharmacotherapy.

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.

J. McMurray, S. Pocock, M. Simoons, 2013, European heart journal.

Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration

O. Franco, A. Hofman, G. Bergström, 2014, European journal of preventive cardiology.

individual-participant-data from 20 prospective studies of the PROG-IMT collaboration Inflammatory markers and extent and progression of early atherosclerosis : Meta-analysis of

O. Franco, A. Hofman, G. Bergström, 2014 .

Glucose intolerance is associated with C‐reactive protein and intima‐media anatomy of the common carotid artery in patients with coronary heart disease

S. Agewall, T. Jogestrand, L. Henareh, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data.

M. Montaudon, S. Agewall, G. Leurent, 2015, Atherosclerosis.

Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men

B. Fagerberg, S. Agewall, 1996, Angiology.

Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.

B. Fagerberg, S. Agewall, J. Wikstrand, 1995, American journal of hypertension.

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.

B. Fagerberg, S. Agewall, J. Wikstrand, 1997, The American journal of cardiology.

Patients' self-estimated likelihood of taking a statin as prescribed after different types of prognostic information.

S. Agewall, F. Roshan, M. Saeed, 2010, Atherosclerosis.

UEMS training requirements for angiology and vascular medicine: european standards of postgraduate medical specialist training (ETR Document).

A. Gallino, A. Sieron, S. Agewall, 2016, International angiology : a journal of the International Union of Angiology.

Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.

S. Agewall, T. Lyberg, K. Mikkelsen, 2013, Clinical and experimental rheumatology.

Relations of Serum COMP to Cardiovascular Risk Factors and Endothelial Function in Patients with Rheumatoid Arthritis Treated with Methotrexate and TNF-α Inhibitors

S. Agewall, T. Lyberg, Ø. Førre, 2012, The Journal of Rheumatology.

Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group.

B. Fagerberg, S. Agewall, J. Wikstrand, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Acute and stable coronary heart disease: different risk factors.

S. Agewall, 2008, European heart journal.

Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease

S. Agewall, M. Crisby, L. Henareh, 2009, Heart and Vessels.

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men

B. Fagerberg, S. Agewall, J. Wikstrand, 1998, Journal of hypertension.

“Troponin Elevation in Coronary Ischemia and Necrosis”

E. Giannitsis, S. Agewall, 2014, Current Atherosclerosis Reports.

Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.

D. Atar, B. Lindahl, C. Gale, 2020, American heart journal.

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis

S. Agewall, Thao Nguyen, M. Feinberg, 2021, PloS one.

Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.

S. Agewall, M. Småstuen, T. Lyberg, 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis

S. Agewall, N. Ronda, M. Småstuen, 2017, Arthritis Research & Therapy.

Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients

S. Agewall, T. Lyberg, K. Mikkelsen, 2012, Scandinavian journal of rheumatology.

Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity

V. Somers, E. Stranden, S. Agewall, 2012, Heart.

Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations

S. Agewall, T. Jernberg, D. Melki, 2011, Scandinavian cardiovascular journal : SCJ.

Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease

S. Agewall, B. Norman, 2006, Pathophysiology of Haemostasis and Thrombosis.

Microalbuminuria in patients with previous myocardial infarction.

S. Agewall, T. Jogestrand, L. Henareh, 2006, Kidney international.

The burden of heart failure in the general population: a clearer and more concerning picture.

S. Agewall, T. von Lueder, 2018, Journal of thoracic disease.

Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.

S. Agewall, T. Jernberg, D. Melki, 2012, Clinica chimica acta; international journal of clinical chemistry.

Cardiovascular pharmacotherapy and real-world data.

S. Agewall, 2018, European heart journal. Cardiovascular pharmacotherapy.

Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose?

S. Agewall, 2001, Journal of Human Hypertension.

Thyroid Dysfunction in Patients With Myocardial Infarction With Normal Coronary Arteries

S. Agewall, P. Tornvall, 2013, Angiology.

Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men.

B. Fagerberg, S. Agewall, G. Lindstedt, 2001, Atherosclerosis.

Risk Factors for Myocardial Infarction With Normal Coronary Arteries and Myocarditis Compared With Myocardial Infarction With Coronary Artery Stenosis

S. Agewall, T. Jernberg, P. Tornvall, 2012, Angiology.

Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.

D. Atar, J. Cleland, H. Katus, 2019, International journal of cardiology.

Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease

S. Agewall, T. Jogestrand, G. Källner, 2005, Journal of hypertension.

Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness.

B. Fagerberg, S. Agewall, J. Wikstrand, 2000, Stroke.

Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men.

S. Agewall, Fagerberg Björn, 2002, Atherosclerosis.

Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima‐media thickness and clinical outcome during 6 years of follow‐up

B. Fagerberg, G. Berglund, S. Agewall, 2001, Journal of internal medicine.

Multifactorial treatment of hypertensive men at high cardiovascular risk and low‐density lipoprotein cholesterol affinity to human arterial proteoglycans

B. Fagerberg, S. Agewall, O. Wiklund, 1996, European journal of clinical investigation.

Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease

B. Fagerberg, S. Agewall, J. Wikstrand, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease.

J. van der Linden, S. Agewall, T. Jogestrand, 2005, Atherosclerosis.

Stroke was predicted by dimensions of quality of life in treated hypertensive men.

B. Fagerberg, S. Agewall, J. Wikstrand, 1998, Stroke.

A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk

B. Fagerberg, C. Dahlöf, S. Agewall, 1995, Journal of hypertension.

How should we evaluate an open artery in STEMI patients?

S. Agewall, 2005, European heart journal.

Oral snuff impairs endothelial function in healthy snuff users

S. Agewall, M. Rohani, M. Rohani, 2004, Journal of internal medicine.

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.

B. Lindahl, S. Agewall, P. Tornvall, 2019, Clinical chemistry.

ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries.

J. Hochman, S. Agewall, R. Tavella, 2019, International journal of cardiology.

Quality of life and insulin resistance in patients with coronary heart disease

S. Agewall, L. Henareh, 2008, Coronary artery disease.

Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit.

S. Agewall, T. Olsson, C. Löwbeer, 2007, The American journal of cardiology.

The new definition of myocardial infarction—Can we use it?

S. Agewall, C. Löwbeer, 2005, Clinical cardiology.

Evaluation of point-of-care test systems using the new definition of myocardial infarction.

S. Agewall, 2003, Clinical biochemistry.

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis

T. Jenssen, S. Agewall, S. O. Kolset, 2021, PloS one.

Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.

J. Tamargo, G. Rosano, J. Kaski, 2020, European heart journal. Cardiovascular pharmacotherapy.

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk

S. Agewall, 1999 .

[New guidelines for angina pectoris].

S. Agewall, 2014, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.

K. Schenck-Gustafsson, S. Agewall, T. Jernberg, 2019, The American journal of medicine.

Low self-estimated quality of life after myocardial infarction and future cardiovascular risk.

S. Agewall, L. Henareh, 2012, International journal of cardiology.

Ivabradine for heart failure: regulatory differences in Europe and United States.

D. Atar, S. Agewall, V. Serebruany, 2019, European Heart Journal - Cardiovascular Pharmacotherapy.

Ivabradine: an hypothesis generating study--an important link between bench and bedside.

E. Wellnhofer, S. Agewall, 2011, Atherosclerosis.

Stefan Agewall, Editor-in-Chief of new EHJ Cardiovascular Pharmacotherapy journal

S. Agewall, 2014 .

Optimizing individual heart failure treatment

S. Agewall, 2022 .

Coronary artery disease and arrhythmias.

S. Agewall, 2017, European heart journal. Cardiovascular pharmacotherapy.

Focus on different aspects of atrial fibrillation.

S. Agewall, 2022, European heart journal. Cardiovascular pharmacotherapy.

Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels.

D. Atar, S. Agewall, M. Melsom, 2011, Clinical Laboratory.

Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries

S. Agewall, E. Svenungsson, P. Tornvall, 2021, Journal of internal medicine.

Non-alcoholic fatty liver disease and cardiovascular disease.

R. Santos, S. Agewall, 2012, Atherosclerosis.

Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma.

P. Hjemdahl, S. Agewall, B. Persson, 1989, Journal of hypertension.

Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men

B. Fagerberg, S. Agewall, 2002, Clinical cardiology.

New input on antiplatelet treatment and registry studies.

S. Agewall, 2018, European heart journal. Cardiovascular pharmacotherapy.

Medical Misinformation.

Sunil V. Rao, A. Dominiczak, C. Grines, 2019, Circulation.

Antiplatelet treatment in coronary syndrome.

S. Agewall, 2021, European heart journal. Cardiovascular pharmacotherapy.

Toward personalized medicine for cardiovascular pharmacotherapy.

J. Tamargo, S. Agewall, K. Hasegawa, 2022, European heart journal.

Femoral artery wall morphology, hemostatic factors and intermittent claudication: ultrasound study in men at high and low risk for atherosclerotic disease.

B. Fagerberg, S. Agewall, J. Wikstrand, 1996, Haemostasis.

Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study

K. Cederlund, M. Ugander, S. Agewall, 2021, Clinical cardiology.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Marco Valgimigli, Jeroen J. Bax, William Wijns, 2019, European heart journal.

Prevention is still the key to success.

S. Agewall, 2022, European heart journal. Cardiovascular pharmacotherapy.

Atrial fibrillation in registries.

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Metabolic control, anticoagulation, and gender aspects.

S. Agewall, 2017, European heart journal. Cardiovascular pharmacotherapy.

Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk.

B. Fagerberg, C. Dahlöf, S. Agewall, 1996, American journal of hypertension.

Levosimendan: perpetuum mobile?

D. Atar, S. Agewall, 2007, European heart journal.

Troponin and exercise.

S. Agewall, T. Gresslien, 2016, International journal of cardiology.

Second year of a journal.

S. Agewall, 2016, European heart journal. Cardiovascular pharmacotherapy.

Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.

Deepak L. Bhatt, G. Hindricks, R. de Caterina, 2022, European heart journal.

Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life.

K. Schenck-Gustafsson, S. Agewall, T. Jernberg, 2017, The American journal of cardiology.

Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate

G. Rosano, I. Spoletini, S. Agewall, 2019, European heart journal supplements : journal of the European Society of Cardiology.

Minimizing bleeding events.

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Antiplatelet treatment in acute coronary syndrome. Still an issue.

S. Agewall, 2019, European heart journal. Cardiovascular pharmacotherapy.

Adherence to guidelines, compliance to treatment, and treatment quality.

S. Agewall, 2018, European heart journal. Cardiovascular pharmacotherapy.

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Jeroen J. Bax, G. Hindricks, O. Alfieri, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Different aspects of giving the optimal antiplatelet treatment.

S. Agewall, 2021, European heart journal. Cardiovascular pharmacotherapy.

Fluoroquinolone use and valvular heart disease: is the jury still out?

J. Tamargo, S. Agewall, 2021, European heart journal.

New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose.

G. Lip, K. Huber, S. Agewall, 2017, European journal of internal medicine.

Lipids and antithrombotic treatment.

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Focus on subpopulations of atrial fibrillation patients.

S. Agewall, 2020, European heart journal. Cardiovascular pharmacotherapy.

Unsolved pharmacological issues with cardiology.

S. Agewall, 2021, European Heart Journal - Cardiovascular Pharmacotherapy.

Interpreting clinical trials: the ‘Beautiful’ case

D. Atar, S. Agewall, 2009, Fundamental & clinical pharmacology.

Microalbuminuria in treated hypertensive men at high risk of coronary disease

B. Fagerberg, S. Agewall, B. Persson, 1993, Journal of hypertension.

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events

B. Lewis, J. Tamargo, S. Agewall, 2022, European heart journal. Cardiovascular pharmacotherapy.

Cardiovascular pharmacotherapy.

S. Agewall, 2018, European heart journal. Cardiovascular pharmacotherapy.

Adherence to guidelines and registry data.

S. Agewall, 2017, European heart journal. Cardiovascular pharmacotherapy.

Adherence to pharmacological treatment: how can we improve?

S. Agewall, 2021, European heart journal. Cardiovascular pharmacotherapy.

Anticoagulation, atherosclerosis, and heart failure.

S. Agewall, 2017, European heart journal. Cardiovascular pharmacotherapy.

Morphine in acute heart failure.

S. Agewall, 2017, Journal of thoracic disease.

Morphine in myocardial infarction: balancing on the tight rope.

D. Atar, S. Agewall, 2016, European heart journal.

Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?

S. Agewall, B. Griffin, 2012, Atherosclerosis.

Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension.

B. Fagerberg, S. Agewall, J. Wikstrand, 1999, Stroke.

Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries

K. Cederlund, M. Ugander, S. Agewall, 2022, JACC: Cardiovascular Imaging.

2018 ESC Guidelines for the diagnosis and management of syncope

Christophe Leclercq, Raffaello Furlan, Rose Anne Kenny, 2018, European heart journal.

Medical Misinformation: Vet the Message!

Sunil V. Rao, A. Dominiczak, C. Grines, 2019, Journal of the American Heart Association.

Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination

B. Fagerberg, S. Agewall, B. Persson, 2002, British journal of biomedical science.

Sick leave and a smoking ban.

S. Agewall, 2014, European heart journal.

The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) – a case-control study using historical controls from a previous study with similar inclusion criteria

K. Cederlund, M. Ugander, S. Agewall, 2017, BMC Cardiovascular Disorders.

Challenges in Cardiovascular Pharmacogenomics Implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

B. Lewis, M. Caulfield, M. Pirmohamed, 2021, European heart journal. Cardiovascular pharmacotherapy.

Ian Graham, Gabriele Riccardi, Eduardo Alegria, 2011, Atherosclerosis.

Physical exertion may cause high troponin levels.

S. Agewall, S. Tjora, 2011, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Troponin rise in healthy subjects during exercise test.

S. Agewall, S. Tjora, H. Gjestland, 2011, International journal of cardiology.

Cardiovascular magnetic resonance imaging commonly identifies a definitive diagnosis following normal echocardiography in myocardial infarction with nonobstructed coronary arteries

K. Cederlund, M. Ugander, S. Agewall, 2022, medRxiv.

2015 ESC Guidelines for the diagnosis and management of pericardial diseases

Jeroen J. Bax, P. Kirchhof, G. Lip, 2015, European heart journal.

Unsolved issues in oral anticoagulation treatment in atrial fibrillation.

S. Agewall, 2019, European heart journal. Cardiovascular pharmacotherapy.

Old and new drugs in cardiovascular pharmacotherapy.

S. Agewall, 2019, European heart journal. Cardiovascular pharmacotherapy.

New ESC/EACTS Guidelines for the management of atrial fibrillation.

J. Camm, S. Agewall, 2016, European heart journal. Cardiovascular pharmacotherapy.

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.

E. Antman, E. Braunwald, S. Murphy, 2007, Journal of the American College of Cardiology.

Never too late: a commentary on "Impact of age, sex and exercise on brachial and popliteal artery remodelling in humans".

S. Agewall, J. Barth, 2010, Atherosclerosis.

The ArthritisInflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Early Prediction of Increased Arterial Stiffness in Patients with Chronic

D. Atar, S. Agewall, A. Semb, 2011 .

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies

S. Agewall, F. Zimetti, F. Bernini, 2022, Journal of clinical medicine.

Letter to the Editor: Snus is not Harmless!

S. Agewall, 2003, European Journal of Epidemiology.

Morphine in the treatment of acute pulmonary oedema--Why?

S. Agewall, Christoffer Ellingsrud, Stefan Agewall, 2016, International journal of cardiology.

[Morphine in the treatment of acute pulmonary oedema].

S. Agewall, Christoffer Ellingsrud, 2014, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Some Aspects of Preventing Coronary Heart Disease

S. Agewall, 2012, Angiology.

[ESC/EAS Guidelines for the management of dyslipidaemias].

M. Taskinen, G. De Backer, S. Agewall, 2011, Revista espanola de cardiologia.

Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Jeroen J. Bax, P. Kolh, I. Simpson, 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

The cost‐effectiveness of a cardiovascular multiple‐risk‐factor intervention programme in treated hypertensive men

B. Fagerberg, M. Johannesson, T. Hedner, 1995, Journal of internal medicine.

Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing

B. Lewis, J. Tamargo, A. Coats, 2020, European Heart Journal - Cardiovascular Pharmacotherapy.

Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF).

B. Lewis, J. Tamargo, G. Rosano, 2020, European heart journal. Cardiovascular pharmacotherapy.

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus

S. Agewall, L. Henareh, 2012, Cardiovascular Diabetology.

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis

S. Agewall, T. Mollnes, K. Mikkelsen, 2022, PloS one.

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

S. Agewall, T. Lyberg, T. Mollnes, 2019, PloS one.

'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias.

M. Taskinen, G. De Backer, P. Filardi, 2011, European heart journal.

The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

B. Lewis, M. Caulfield, M. Pirmohamed, 2021, European heart journal. Cardiovascular pharmacotherapy.

Comprehensive efforts to increase adherence to statin therapy

Harald H H W Schmidt, B. Lewis, J. Tamargo, 2017, European heart journal.

The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials.

B. Lewis, G. Rosano, K. Huber, 2019, European heart journal. Cardiovascular pharmacotherapy.

Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review

P. Raggi, S. Agewall, G. Sardella, 2018, European heart journal. Cardiovascular pharmacotherapy.

[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]

Marco Valgimigli, Marco Roffi, Pascal Vranckx, 2018, Kardiologia polska.

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

Malte Kelm, Ralph B D'Agostino, Jacek Kubica, 2015, Annals of internal medicine.

Acute responses to phytoestrogens in small arteries from men with coronary heart disease.

L. Poston, S. Agewall, K. Kublickiene, 2006, American journal of physiology. Heart and circulatory physiology.

Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review

B. Lewis, J. Tamargo, G. Rosano, 2018, European heart journal. Cardiovascular pharmacotherapy.

Intima–media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction

S. Agewall, T. Jogestrand, L. Henareh, 2005, Journal of hypertension.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Jeroen J. Bax, R. de Caterina, B. Gorenek, 2009 .

Gender differences in the effects of cardiovascular drugs

D. Atar, B. Lewis, J. Tamargo, 2017, European heart journal. Cardiovascular pharmacotherapy.

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

G. Lip, I. V. Van Gelder, A. Goette, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society

G. Lip, I. V. Van Gelder, B. Gorenek, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

G. Lip, I. V. Van Gelder, A. Goette, 2017, European journal of preventive cardiology.

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.

D. Atar, B. Lewis, J. Tamargo, 2019, European heart journal. Cardiovascular pharmacotherapy.

I. V. Van Gelder, A. Goette, E. Benjamin, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials.

B. Lewis, S. Pocock, J. Tamargo, 2020, European heart journal. Cardiovascular pharmacotherapy.

European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723.

S. Agewall, 2019, European heart journal. Cardiovascular pharmacotherapy.

Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study

D. Atar, H. Katus, S. Agewall, 2013, European Journal of Clinical Pharmacology.

COPD predicts mortality in HF: the Norwegian Heart Failure Registry.

D. Atar, S. Agewall, S. Simard, 2010, Journal of cardiac failure.

Reflexogenic neuronal and humoral responses to selective stimulation of low‐pressure cardiopulmonary receptors in man

S. Agewall, B. Persson, B. Karlberg, 1991, Journal of internal medicine.

Reduced quality of life after myocardial infarction in women compared with men

S. Agewall, L. Henareh, M. Berglund, 2004, Clinical cardiology.

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

D. Atar, J. Cleland, H. Katus, 2017, Clinical Research in Cardiology.

Insulin Sensitivity and Hemostatic Factors in Clinically Healthy 58-year-old Men

B. Fagerberg, A. Lindahl, S. Agewall, 2000, Thrombosis and Haemostasis.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Jeroen J. Bax, P. Kirchhof, G. Lip, 2016, European journal of heart failure.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

P. Ponikowski, B. Lewis, G. Filippatos, 2018, European heart journal. Cardiovascular pharmacotherapy.

Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure.

D. Atar, J. Cleland, H. Katus, 2017, International journal of cardiology.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with RAAS-inhibitors-Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

P. Ponikowski, B. Lewis, G. Filippatos, 2018 .

Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.

Harald H H W Schmidt, B. Lewis, J. Tamargo, 2015, European heart journal.

Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.

C. O'connor, M. Gheorghiade, F. Zannad, 2013, International journal of cardiology.

Morten Wang Fagerland, D. Atar, S. Agewall, 2014, Sleep medicine.

The efficacy of multiple risk factor intervention in treated hypertensive men during long‐term follow up

B. Fagerberg, S. Agewall, J. Wikstrand, 1994, Journal of internal medicine.

Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction

L. Brodin, S. Agewall, B. Lind, 2007, Clinical physiology and functional imaging.

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

D. Atar, M. Krucoff, A. Lincoff, 2015, American heart journal.

Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

B. Lewis, J. Tamargo, K. Kjeldsen, 2021, European heart journal. Cardiovascular pharmacotherapy.

Is carbohydrate-deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients?

B. Fagerberg, S. Agewall, P. Lundberg, 1994, Clinical chemistry.

Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

S. Agewall, J. Rivera‐Caravaca, G. Lip, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.

D. Atar, S. Solomon, K. Dickstein, 2019, American heart journal.

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials.

P. Kirchhof, K. Swedberg, J. Caro, 2014, European heart journal.

Plasma biomarker levels and non‐obstructive coronary artery disease determined by coronary computed tomography angiography

K. Cederlund, S. Agewall, P. Tornvall, 2018, Clinical physiology and functional imaging.

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative

D. Atar, K. Dickstein, B. Pitt, 2015, European journal of heart failure.

Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

D. Atar, J. Cleland, S. Agewall, 2021, Clinical Research in Cardiology.

Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.

S. Agewall, T. Jogestrand, L. Henareh, 2009, Thrombosis research.

Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study

D. Atar, J. Cleland, H. Katus, 2018, European heart journal. Cardiovascular pharmacotherapy.

Ultrasound and radiology surrogate endpoints in pharmacological studies.

J. Zamorano, L. Badano, S. Agewall, 2012, Atherosclerosis.

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

B. Lewis, J. Tamargo, G. Rosano, 2016, European heart journal. Cardiovascular pharmacotherapy.

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

B. Lewis, J. Tamargo, G. Rosano, 2016, European heart journal.

Treatment with β‐blockers—the value of an even plasma concentration over 24 h

S. Agewall, M. Kendall, 1997 .

Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe

D. Atar, J. Cleland, H. Katus, 2019, Heart.

Coronary Heart Disease Risk Factors Age Male gender Family history of CHD Smoking Unhealthy food choices Physical inactivity Psychosocial factors Abdominal obesity Hypertension Hypercholesterolemia Diabetes mellitus

S. Agewall, 2011 .

Does a glass of red wine improve endothelial function?

R. Doughty, N. Sharpe, S. Agewall, 2000, European heart journal.

Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4

S. Agewall, L. Diep, P. Stenvinkel, 2014, Angiology.

Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response

S. Agewall, J. Hisdal, T. Omland, 2013, Heart.

Evaluation of endothelial function using finger plethysmography

S. Agewall, A. K. Faizi, D. W. Kornmo, 2009, Clinical physiology and functional imaging.

Prevention of cardiovascular disease in rheumatoid arthritis.

M. Wasko, S. Agewall, E. Svenungsson, 2015, Autoimmunity reviews.

Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study

K. Cederlund, S. Agewall, P. Tornvall, 2015, BMC Cardiovascular Disorders.

Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients

S. Agewall, K. Mikkelsen, I. Hollan, 2011, Scandinavian journal of rheumatology.

Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions.

R. Doughty, N. Sharpe, S. Agewall, 2001, Clinical physiology.

Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation

R. Doughty, N. Sharpe, S. Agewall, 1999, Heart.

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study

D. Atar, S. Agewall, H. Dagfinrud, 2011, Annals of the rheumatic diseases.

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk

S. Yusuf, E. Lonn, D. Grobbee, 2020, Circulation.

Troponins in heart failure.

E. Giannitsis, S. Agewall, T. Omland, 2015, Clinica chimica acta; international journal of clinical chemistry.

Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease

Morten Wang Fagerland, D. Atar, S. Agewall, 2011, Scandinavian journal of urology and nephrology.

Early arterial abnormalities in young adulthood.

S. Agewall, P. Rubba, 2012, Atherosclerosis.

Gender differences among Norwegian patients with heart failure.

D. Atar, S. Agewall, B. Brandsaeter, 2011, International journal of cardiology.

Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017

D. Atar, T. Kjellstrom, S. Agewall, 2018, Scandinavian cardiovascular journal : SCJ.

The Effects of Climate Change on Cardiac Health

D. Atar, T. Kjellstrom, P. Armstrong, 2015, Cardiology.

Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

K. Cederlund, M. Ugander, S. Agewall, 2021, JACC. Cardiovascular imaging.

Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease

S. Agewall, K. Kublickiene, Anton Paier, 2009, Heart and Vessels.

Post‐occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated

B. Fagerberg, S. Agewall, J. Wikstrand, 2002, Clinical physiology and functional imaging.

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

R. Leone, S. Agewall, M. Småstuen, 2017, PloS one.

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.

S. Agewall, 1999, Journal of internal medicine.

Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

K. Schenck-Gustafsson, S. Agewall, T. Jernberg, 2018, The American journal of medicine.

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

G. Rosano, I. Spoletini, S. Agewall, 2019, Cardiac failure review.

The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!

S. Agewall, 2016, European heart journal. Cardiovascular pharmacotherapy.

The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale

G. Bergström, E. Lonn, M. Hanefeld, 2020, Gerontology.

A tailor-made suit always fits best.

S. Agewall, 2023, European heart journal. Cardiovascular pharmacotherapy.

Optimizing individual heart failure treatment.

S. Agewall, 2022, European heart journal. Cardiovascular pharmacotherapy.

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.

D. Atar, B. Lewis, J. Tamargo, 2019, European heart journal.

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.

G. Lip, D. Atar, J. Morais, 2013, European heart journal.

D9 - Urinary albumin excretion is associated with intima-media thickness of the carotid artery in hypertensive men with non-insulin-depenoent diabetes mellitus

B. Fagerberg, S. Agewall, J. Wikstrand, 1995 .

Echogenicity of the carotid intima–media complex and cardiovascular risk factors

E. Stranden, S. Agewall, T. Jogestrand, 2012, Clinical physiology and functional imaging.

Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima‐media thickness

S. Agewall, T. Gustafsson, T. Jogestrand, 2014, Clinical physiology and functional imaging.

2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS

P. Kirchhof, U. Schotten, G. Hindricks, 2017 .

The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease

A. Manouras, F. Bergholm, L. Brodin, 2014, Clinical physiology and functional imaging.

Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study

D. Atar, H. Katus, S. Agewall, 2013, European Journal of Clinical Pharmacology.

Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?

S. Agewall, 2003, Current vascular pharmacology.

Focus on prevention in diabetes mellitus and lipid disorder.

S. Agewall, 2023, European heart journal. Cardiovascular pharmacotherapy.

Early Prediction of Increased Arterial Stiffness in Patients with Chronic Inflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Arthritis

D. Atar, S. Agewall, A. Semb, 2011, The Journal of Rheumatology.

Requirements for angiology/vascular medicine.

A. Gallino, A. Sieron, S. Agewall, 2013, International angiology : a journal of the International Union of Angiology.

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022.

J. Tamargo, P. Ferdinandy, E. Grove, 2023, European heart journal. Cardiovascular pharmacotherapy.

high-risk hypertensive patients. Risk Intervention Study (RIS) Group Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in

B. Fagerberg, S. Agewall, J. Wikstrand, 2011 .

Association of Intima‐Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta‐Analysis of 20 Prospective Studies

N. Sattar, L. Lind, P. Calder, 2023, Journal of the American Heart Association.

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

B. Lewis, J. Tamargo, G. Rosano, 2022, European heart journal. Cardiovascular pharmacotherapy.

Medical Misinformation: Vet the Message!

A. Dominiczak, C. Grines, A. Baranchuk, 2019, Circulation.

[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism].

P. Kolh, D. Fitzmaurice, W. Ageno, 2014, Kardiologia polska.

ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry.

Morten Wang Fagerland, D. Atar, S. Agewall, 2015, European heart journal. Cardiovascular pharmacotherapy.

Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium

O. Franco, A. Hofman, G. Bergström, 2019, European journal of preventive cardiology.

Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology ( ESC ) Endorsed by the European Respiratory Society ( ERS )

P. Kolh, D. Fitzmaurice, W. Ageno, 2014 .

All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.

D. Atar, S. Agewall, V. Serebruany, 2019, American journal of therapeutics.

[Guidelines on cardiovascular disease prevention in clinical practice].

A. Hoes, G. De Backer, A. Franck, 2005, Revue medicale de Liege.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

G. Hindricks, F. Crea, A. Kastrati, 2017, Revista espanola de cardiologia.

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Baris Gencer, Marco Valgimigli, Marco Roffi, 2011 .

G. Hindricks, F. Crea, A. Kastrati, 2018, European heart journal.

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

M. Taskinen, G. De Backer, P. Filardi, 2011, Atherosclerosis.

ESC/EAS Guidelines for the Management of Dyslipidaemias

M. Taskinen, P. Filardi, S. Agewall, 2013 .

P. Kolh, M. Taskinen, P. Filardi, 2011, European heart journal.

Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus

D. Atar, S. Agewall, A. Clark, 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

[ESC/EAS Guidelines for the management of dyslipidaemias].

M. Taskinen, G. De Backer, S. Agewall, 2011, Revista espanola de cardiologia.

S. Agewall, T. Jernberg, P. Tornvall, 2013, Journal of internal medicine.

Sweet dreams might be bad.

S. Agewall, A. Nesvold, 2011, International journal of cardiology.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of

B. Lewis, J. Mehilli, S. Windecker, 2016 .

K. Cederlund, S. Agewall, P. Tornvall, 2022, European Heart Journal - Quality of Care and Clinical Outcomes.

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Jeroen J. Bax, P. Kolh, D. Fitzmaurice, 2014, European heart journal.

RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action.

D. Atar, S. Agewall, Alexandra Schneider, 2023, Journal of the American College of Cardiology.

ESC/EAS Guidelines for the Management of Dyslipidaemias

M. Taskinen, P. Filardi, S. Agewall, 2013 .

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

M. Taskinen, G. De Backer, P. Filardi, 2011, Atherosclerosis.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

Jeroen J. Bax, S. Achenbach, B. Gersh, 2020, Russian Journal of Cardiology.

How to save six million people per year.

S. Agewall, 2015, Atherosclerosis.

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

D. Atar, R. de Caterina, G. Rosano, 2016, European heart journal.

Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group.

B. Fagerberg, S. Agewall, J. Wikstrand, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Jeroen J. Bax, R. de Caterina, B. Gorenek, 2014 .

Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure.

D. Atar, J. Cleland, H. Katus, 2017, International journal of cardiology.

Acute and stable coronary heart disease: different risk factors.

S. Agewall, I. Serre, Mathieu Granier, 2008, European heart journal.

Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.

S. Agewall, T. Jernberg, S. Lind, 2012, Clinica chimica acta; international journal of clinical chemistry.

Automatic identification of variables in epidemiological datasets using logic regression

Dong Zhao, Jing Liu, Albert Hofman, 2017, BMC Medical Informatics and Decision Making.

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study

D. Atar, S. Agewall, H. Dagfinrud, 2011, Annals of the rheumatic diseases.

High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis

S. Agewall, I. Hollan, J. E. Whist, 2023, PLoS ONE.

Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study

D. Atar, H. Katus, S. Agewall, 2015, Circulation. Heart failure.

All-cause mortality and cardiovascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the Food and Drug Administration Adverse Event Reporting System

D. Atar, S. Agewall, V. Serebruany, 2018 .

EVALUATION OF A STRUCTURALIZED SICK-LEAVE PROGRAMME COMPARED WITH USUAL CARE SICK-LEAVE MANAGEMENT FOR PATIENTS AFTER AN ACUTE MYOCARDIAL INFARCTION

S. Agewall, Lars Tjessem, 2023, Journal of rehabilitation medicine.